Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting

European Journal of Preventive Cardiology

Volumn 21, Issue 9, 2014, Pages 1125-1133

  Völler, Heinz ^a,b   Gitt, Anselm ^c   Jannowitz, Christina ^d   Karoff, Marthin ^e   Karmann, Barbara ^d   Pittrow, David ^f   Reibis, Rona ^a,g   Hildemann, Steven ^d,h  

^a Klinik Am See   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MSD Sharp and Dohme GmbH   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g Sports Medicine and Sports Orthopaedics   (Germany)

^h UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Cardiac rehabilitation; chronic kidney disease; control rates; dyslipidemia; glomerular filtration rate; lipids; registry; risk factor

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ATORVASTATIN; FLUINDOSTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; FITNESS; FUNCTIONAL STATUS; GLOMERULUS FILTRATION RATE; HEART REHABILITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMORBIDITY; EXERCISE TOLERANCE; FOLLOW UP; GERMANY; KINESIOTHERAPY; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSIOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DEMOGRAPHY; DISEASE CLASSIFICATION; EXERCISE TEST; FAMILY HISTORY; HOSPITAL PATIENT; PATIENT INFORMATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMORBIDITY; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; GERMANY; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PATIENT COMPLIANCE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84898546836     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313482285     Document Type: Article

References (31)

1. Stevens LA, Viswanathan G, Weiner DE. Chronic kidney disease and end-stage renal disease in the elderly population: Current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis. 2010 ; 17: 293-301
2. Rothenbacher D, Klenk J, Denkinger M, et al. Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equations. BMC Public Health. 2012 ; 12: 343-343
3. Van Pottelbergh G, Bartholomeeusen S, Buntinx F, et al. The prevalence of chronic kidney disease in a Flemish primary care morbidity register. Age Ageing. 2012 ; 41: 231-233
4. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 ; 351: 1296-1305
5. Astor BC, Hallan SI, Miller ER 3rd, et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008 ; 167: 1226-1234
6. Murphy CA, Robb SD, Weir RAP, et al. Declining renal function after myocardial infarction predicts poorer long-term outcome. Eur J Cardiovasc Prev Rehab. 2010 ; 17: 181-186
7. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002 ; 39: S1- - S266
8. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003 ; 108: 2154-2169
9. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur J Prev Cardiol 2012; 19: 585-667.
10. Venkataraman R, Sanderson B, Bittner V. Outcomes in patients with chronic kidney disease undergoing cardiac rehabilitation. Am Heart J. 2005 ; 150: 1140-1146
11. Karoff M, Held K, Bjarnason-Wehrens B. Cardiac rehabilitation in Germany. Eur J Cardiovasc Prev Rehabil. 2007 ; 14: 18-27
12. Junger C, Rauch B, Schneider S, et al. Effect of early short-term cardiac rehabilitation after acute ST-elevation and non-ST-elevation myocardial infarction on 1-year mortality. Curr Med Res Opin. 2010 ; 26: 803-811
13. Alter DA, Oh PI, Chong A. Relationship between cardiac rehabilitation and survival after acute cardiac hospitalization within a universal health care system. Eur J Cardiovasc Prev Rehabil. 2009 ; 16: 102-113
14. Bestehorn K, Wegscheider K, Voller H. Contemporary trends in cardiac rehabilitation in Germany: Patient characteristics, drug treatment, and risk-factor management from 2000 to 2005. Eur J Cardiovasc Prev Rehabil. 2008 ; 15: 312-318
15. Völler H, Reibis R, Pittrow D, et al. Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: Risk factors, treatment and target level attainment. Curr Med Res Opin. 2009 ; 25: 879-890
16. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006 ; 145: 247-254
17. Glassock RJ, Winearls C. Screening for CKD with eGFR: Doubts and dangers. Clin J Am Soc Nephrol. 2008 ; 3: 1563-1568
18. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Updated 2002. http://www.kidney.org/professionals/kdoqi/guidelines-ckd/toc.htm (accessed 2 December 2012).
19. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007 ; 298: 2038-2047
20. Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry Pharmacokinetics in Patients with Impaired Renal Function - Study Design, Data Analysis, and Impact on Dosing and Labeling. Rockville, March 2010.
21. Cleeman JI, Grundy SM, Becker D, et al. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001 ; 285: 2486-2497
22. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003; 41: I-IV, S1-91.
23. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised placebo-controlled trial. Lancet. 2013 ; 377: 2181-2192
24. Pittrow D, Kirch W, Bramlage P, et al. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol. 2004 ; 60: 135-142
25. Beddhu S, Baird BC, Zitterkoph J, et al. Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am Soc Nephrol. 2009 ; 4: 1901-1906
26. Tjonna AE, Lee SJ, Rognmo O, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: A pilot study. Circulation. 2008 ; 118: 346-354
27. Robinson-Cohen C, Katz R, Mozaffarian D, et al. Physical activity and rapid decline in kidney function among older adults. Arch Intern Med. 2009 ; 169: 2116-2123
28. Finkelstein J, Joshi A, Hise MK. Association of physical activity and renal function in subjects with and without metabolic syndrome: A review of the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006 ; 48: 372-382
29. Bronas UG. Exercise training and reduction of cardiovascular disease risk factors in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2009 ; 16: 449-458
30. McClellan WM, Newsome BB, McClure LA, et al. Chronic kidney disease is often unrecognized among patients with coronary heart disease: The REGARDS Cohort Study. Am J Nephrol. 2009 ; 29: 10-17
31. Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis. 2010 ; 17: 225-236